Home/Filings/4/0001437749-12-010278
4//SEC Filing

Najafi Ramin 4

Accession 0001437749-12-010278

CIK 0001389545other

Filed

Oct 11, 8:00 PM ET

Accepted

Oct 12, 3:49 PM ET

Size

5.4 KB

Accession

0001437749-12-010278

Insider Transaction Report

Form 4
Period: 2012-10-10
Najafi Ramin
DirectorChief Executive OfficerOther
Transactions
  • Award

    Option (right to buy)

    2012-10-10+65,000679,852 total
    Exercise: $1.29From: 2013-10-10Exp: 2022-10-10Common Stock (65,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the option shares vest and become exercisable on the first anniversary of the date of grant, and the balance of the option shares vest and become exercisable in a series of twelve (12) equal installments upon the completion of each three (3) months beginning October 10, 2012.

Issuer

NovaBay Pharmaceuticals, Inc.

CIK 0001389545

Entity typeother

Related Parties

1
  • filerCIK 0001410081

Filing Metadata

Form type
4
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 3:49 PM ET
Size
5.4 KB